Department of Molecular Medicine　Atomic Bomb Disease Institute

■ PUBLICATIONS

(２０２０年)
A 欧文 A-a
1. Shimamura M, Kurashige T, Kuatov R, Nagayama Y: Acceleration of BRAFV600E- mediated thyroid carcinogenesis by TGFβ signal deficiency. Endocrine 69(3): 571-577, 2020 doi: 10.1007/s12020-020-02298-1. Epub 2020 Apr 12. (IF: 3.633)

2.Mussazhanova Z, Shimamura M (equal contribution), Kurashige T, Ito M, Nakashima M, Nagayama Y: Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors. Cancer Sci 111(8): 2014-2823, 2020 doi: 10.1111/cas.14501. Epub 2020 Jun 30. (IF: 6.716)

3.Davies TF, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M, Eckstein AK, Green AS, Kahaly GJ: Graves ' disease. Nat Rev Dis Primers 6(1): 52 2020 doi: 10.1038/s41572-020-0184-y. (IF: 52.329)

4.Nagayama Y: Commentary: Excessive iodine promotes pyroptosis of thyroid follicular epithelial cells in Hashimoto's thyroiditis through the ROS-NF-κB-NLRP3 pathway. Front Endocrinol - Thyroid Endocrinology 11: 581 2020 doi: 10.3389/fendo.2020.00581. eCollection 2020. (IF: 5.555)

5.Kurashige T, Shimamura M, Nagayama Y: Re-evaluation of the effect of iodine on thyroid cell survival and function with PCCL3 and Nthy-ori 3-1 cells. J Endocr Soc 4(11): bvaa146 2020 doi: 10.1210/jendso/bvaa146. eCollection 2020 Nov 1.

6.Kurashige T, Nakajima Y, Shimamura M, Yamada M, Nagayama Y: Hormonal regulation of autophagy in thyroid PCCL3 cells and the thyroids of male mice. J Endocr Soc 4(7): bvaa054 2020 doi: 10.1210/jendso/bvaa054. eCollection 2020 Jul 1.

7. Kakomi S, Nakayama T, Shang Y, Tsuruoka C, Sunaoshi M, Morioka T, Shimada Y, Kakinuma S, Tachibana A: The effects of short-term calorie restriction on mutations in the spleen cells of infant-irradiated mice. J Radiat Res. 61(2): 187- 196, 2020 doi: 10.1093/jrr/rrz078.. (IF: 2.724)

8.Yamada K, Yamaguchi I, Urata H，Hayashida N: Survey of awareness of radiation disasters among firefighters in a Japanese prefecture without nuclear power plants． PLos One 15(7): e0236640 2020 doi: 10.1371/journal.pone.0236640. (IF: 3.24)

(２０１９年)
A 欧文 A-a
1. Kurashige T, Nakajima Y, Shimamura M, Matsuyama M, Yamada M, Nakashima M, Nagayama Y: Basal autophagy deficiency causes thyroid follicular epithelial cell death in mice. Endocrinology. 160 (9): 2085?2092, 2019. (IF:3.8)

2. Nagayama Y, Mishima H: Heterogenous nature of gene expression patterns in BRAF-like, classical papillary thyroid carcinomas with BRAFV600E. Endocrine. 66 (3): 607-613, 2019. (IF:3.296)

3. Yamada Y, Orita M, Shinkawa T, Urata H, Kondo H, Takamura N: Nurses’ interest in nuclear disaster medicine future capacity building. Journal of Radiation Research. 60 (3): 333-334,2019 (IF:2.014)

4. Nagatorni N，Yamaguchi Y，Shinkawa T，Taira Y，Urata H，Orita M，Takamura N: Radiation education for nurses working at middle-sized hospitals in Japan．Journal of Radiation Research．60 (5): 717-718, 2019. (IF:2.014)

(２０１８年）
1. Nishihara E, Tsugawa M, Ozaki Y, Nagayama Y, Fukata S, Hirokawa M, Ito M, Nishikawa M, Nakamura H, Ito Y, Miyauchi A: Long-term follow-up of a patient with sporadic non-autoimmune hyperthyroidism due to a thyrotropin receptor mutation (D619G). AACE Clin Case Rep 1: e85, 2018.(IF: -)
2. Shimamura M, Shibusawa N, Kurashige T, Hiroki Matsuzaki, Nakashima M, Yamada M, Nagayama Y: Mouse models of sporadic thyroid cancer derived from BRAFV?600E alone or in combination with PTEN haploinsufficiency under physiologic TSH levels. PLoS One 13 (8): e0201365, 2018.(IF: 2.766)
3. Shimamura M, Yamamoto K, Kurashige T, Nagayama Y: Intracellular redox status controls spherogenicity, an in vitro cancer stem cell marker, in thyroid cancer cell lines. Exp Cell Res 370 (2): 699-707, 2018. (IF: 3.309)
4. Yamaguchi T, Orita M, Urata H, Shinkawa T, Taira Y, Takamura N: J Radiat Res 59 (2): 240-241, 2018.(IF: 1.788)
5. Nagayama Y: Radiation Related Thyroid Autoimmunity and Dysfunction. J Radiat Res 59 (S2): ii98-ii107, 2018. (IF: 2.031)
6. Nagayama Y. Review article: Thyroid autoimmunity and thyroid cancer ? the pathological connection: a 2018 update. Horm Metab Res 50 (12):922-931, 2018. (IF: 2.560)

(２０１７年）
1. Nagayama Y. TSH Receptor (Thyrotropin Receptor). Reference Module in Biomedical Sciences. Elsevier. 10-Apr-2017 doi:10.1016/B978-0-12-801238-3.96039-2.
2. Shimamura M, Kurashige T, Mitsutake N, Nagayama Y. Aldehyde dehydrogenase activity plays no functional role in stem cell-like properties in anaplastic thyroid cancer cell lines. Endocrine. 55 (3): 934-943, 2017.
3. Kurashige T, Shimamura M, Nagayama Y. N-acetyl-L-cysteine protects thyroid cells against DNA damage induced by external and internal irradiation. Radiat Environ Biophys. 56 (4): 405-412, 2017.

（２０１０年～２０１６年）

（２００２年～２００９年）

■ BOOKS

（２０１０)
1. Nagayama Y. Animal models of autoimmune thyroid disease. (In) Immunoendocrinology. Eisenbarth G (ed), in press, 2010.
（２００４）
1. Nagayama Y. TSH receptor (thyrotropin receptor). (In) The Encyclopedia of Endocrine Diseases. Martini L. (ed) Academic Press. Vol. 4, 632-635, 2004.
2. Nagayama Y. Gene Therapy for thyroid cancer. (In) Molecular Basis of Thyroid Cancer. Farid NR. (ed) Kluwar Academic Pub. 369-379, 2004.
（２００２）
1. Nagayama Y. The Thyroid stimulating hormone receptor. (In) Thyroid Eye Disease: Diagnosis and Treatment. Dutton JJ and Haik BG (ed), 19-27, 2002.

Department of Molecular Medicine Atomic Bomb Disease Institute

Go to Japanese page

■ PUBLICATIONS

■ BOOKS

Department of Molecular Medicine　Atomic Bomb Disease Institute